Ursell, L. K. et al. The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 146, 1470–1476 (2014).
Google Scholar
Grice, E. A. & Segre, J. A. The human microbiome: our second genome. Annu. Rev. Genom. Hum. Genet. 13, 151–170 (2012).
Google Scholar
Berg, G. et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome 8, 103 (2020).
Google Scholar
Shreiner, A. B., Kao, J. Y. & Young, V. B. The gut microbiome in health and in disease. Curr. Opin. Gastroenterol. 31, 69–75 (2015).
Google Scholar
Hillman, E. T., Lu, H., Yao, T. & Nakatsu, C. H. Microbial ecology along the gastrointestinal tract. Microbes Environ. 32, 300–313 (2017).
Google Scholar
Laterza, L. et al. The gut microbiota and immune system relationship in human graft-versus-host disease. Mediterranean J. Hematol. Infect. Dis. 8, 2016025 (2016).
Google Scholar
Auchtung, T. A. et al. Investigating colonization of the healthy adult gastrointestinal tract by fungi. mSphere. 3, e00092–18 (2018).
Lozupone, C. A. et al. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220–230 (2012).
Google Scholar
Deo, P. N. & Deshmukh, R. Oral microbiome: unveiling the fundamentals. J. Oral. Maxillofac. Pathol. 23, 122–128 (2019).
Google Scholar
Segata, N. et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 13, R42 (2012).
Google Scholar
Dickson, R. P. & Huffnagle, G. B. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog. 11, e1004923 (2015).
Google Scholar
Dickson, R. P., Martinez, F. J. & Huffnagle, G. B. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 384, 691–702 (2014).
Google Scholar
Tong, X. et al. Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial. mBio. 9, e02392–17 (2018).
Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
Google Scholar
Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507–510 (2008).
Google Scholar
Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
Google Scholar
Roberfroid, M. B., Bornet, F., Bouley, C. & Cummings, J. H. Colonic microflora: nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr. Rev. 53, 127–130 (1995).
Google Scholar
Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55–71 (2021).
Google Scholar
Flint, H. J., Scott, K. P., Louis, P. & Duncan, S. H. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9, 577–589 (2012).
Google Scholar
Milani, C. et al. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol. Mol. Biol. Rev. 81, e00036–00017 (2017).
Google Scholar
Rinninella, E. et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 7, 14 (2019).
Amabebe, E., Robert, F. O., Agbalalah, T. & Orubu, E. S. F. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br. J. Nutr. 123, 1127–1137 (2020).
Google Scholar
Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012).
Google Scholar
Guigoz, Y., Doré, J. & Schiffrin, E. J. The inflammatory status of old age can be nurtured from the intestinal environment. Curr. Opin. Clin. Nutr. Metab. Care. 11, 13–20 (2008).
Google Scholar
Hugenholtz, F. & de Vos, W. M. Mouse models for human intestinal microbiota research: a critical evaluation. Cell Mol. Life Sci. 75, 149–160 (2018).
Google Scholar
Cheng, Y. et al. Principles of regulatory information conservation between mouse and human. Nature 515, 371–375 (2014).
Google Scholar
Park, J. C. & Im, S.-H. Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics. Exp. Mol. Med. 52, 1383–1396 (2020).
Google Scholar
Krych, L. et al. Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome. PLoS One 8, e62578 (2013).
Google Scholar
Bohnhoff, M., Drake, B. L. & Miller, C. P. The effect of an antibiotic on the susceptibility of the mouse’s intestinal tract to Salmonella infection. Antibiotics Annu. 3, 453–455 (1955).
Coyte, K. Z. & Rakoff-Nahoum, S. Understanding competition and cooperation within the mammalian gut microbiome. Curr. Biol. 29, R538–R544 (2019).
Google Scholar
Martens, E. C., Chiang, H. C. & Gordon, J. I. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 4, 447–457 (2008).
Google Scholar
Ducarmon, Q. R. et al. Gut Microbiota and colonization resistance against bacterial enteric infection. Microbiol. Mol. Biol. Rev. 83, e00007–19 (2019).
Freter, R. et al. Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect. Immun. 39, 676–685 (1983).
Google Scholar
Kashyap, P. C. et al. Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. Proc. Natl Acad. Sci. USA 110, 17059–17064 (2013).
Google Scholar
Pukatzki, S. et al. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc. Natl Acad. Sci. USA 103, 1528–1533 (2006).
Google Scholar
Russell, A. B. et al. Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475, 343–347 (2011).
Google Scholar
Anderson, M. C. et al. Shigella sonnei encodes a functional T6SS used for interbacterial competition and niche occupancy. Cell Host Microbe 21, 769–776.e763 (2017).
Google Scholar
Whitney, J. C. et al. A broadly distributed toxin family mediates contact-dependent antagonism between gram-positive bacteria. eLife 6, e26938 (2017).
Google Scholar
Davies, E. V., Winstanley, C., Fothergill, J. L. & James, C. E. The role of temperate bacteriophages in bacterial infection. FEMS Microbiol. Lett. 363, fnw015 (2016).
Google Scholar
Furuyama, N. & Sircili, M. P. Outer Membrane Vesicles (OMVs) produced by gram-negative bacteria: structure, functions, biogenesis, and vaccine application. BioMed. Res. Int. 2021, 1490732 (2021).
Google Scholar
Loenen, W. A. M. & Raleigh, E. A. The other face of restriction: modification-dependent enzymes. Nucleic Acids Res. 42, 56–69 (2014).
Google Scholar
Amitai, G. & Sorek, R. CRISPR-Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14, 67–76 (2016).
Google Scholar
Goldfarb, T. et al. BREX is a novel phage resistance system widespread in microbial genomes. EMBO J. 34, 169–183 (2015).
Google Scholar
Sobel, N. Is there a protective role for vaginal flora? Curr. Infect. Dis. Rep. 1, 379–383 (1999).
Google Scholar
Fredricks, D. N., Fiedler, T. L. & Marrazzo, J. M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353, 1899–1911 (2005).
Google Scholar
Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108, 4680–4687 (2011).
Google Scholar
Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra152 (2012).
Google Scholar
Boskey, E. R. et al. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect. Immun. 67, 5170–5175 (1999).
Google Scholar
Watts, D. H. et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J. Infect. Dis. 191, 1129–1139 (2005).
Google Scholar
Peipert, J. F. et al. Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association? Sexually Transmitted Dis. 35, 363–367 (2008).
Google Scholar
Cherpes, T. L. et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 37, 319–325 (2003).
Google Scholar
Schwebke, J. R. & Desmond, R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am. J. Obstet. Gynecol. 196, 517.e511–516 (2007).
Google Scholar
Brotman, RebeccaM. et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J. Infect. Dis. 202, 1907–1915 (2010).
Google Scholar
Leyden, J. J., McGinley, K. J., Mills, O. H. & Kligman, A. M. Propionibacterium levels in patients with and without acne vulgaris. J. Investig. Dermatol. 65, 382–384 (1975).
Google Scholar
Christensen, G. J. M. & Brüggemann, H. Bacterial skin commensals and their role as host guardians. Beneficial Microbes 5, 201–215 (2014).
Google Scholar
Iwase, T. et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465, 346–349 (2010).
Google Scholar
Belkaid, Y. & Segre, J. A. Dialogue between skin microbiota and immunity. Science 346, 954–959 (2014).
Google Scholar
Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877–2013 (2019).
Google Scholar
Farmer, A. D. & Aziz, Q. Mechanisms and management of functional abdominal pain. J. R. Soc. Med. 107, 347–354 (2014).
Google Scholar
Chen, K. et al. Drosophila histone demethylase KDM5 regulates social behavior through immune control and gut microbiota maintenance. Cell Host Microbe 25, 537–552.e538 (2019).
Google Scholar
Bravo, J. A. et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl Acad. Sci. 108, 16050–16055 (2011).
Google Scholar
Buffington, S. A. et al. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165, 1762–1775 (2016).
Google Scholar
Poutahidis, T. et al. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One. 8, e78898 (2013).
Google Scholar
de Theije, C. G. M. et al. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain, Behav. Immun. 37, 197–206 (2014).
Google Scholar
Gilbert, J. A. Social behavior and the microbiome. eLife 4, e07322 (2015).
Google Scholar
Allen, A. P. et al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl. Psychiatry 6, e939 (2016).
Google Scholar
Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167, 1469–1480.e1412 (2016).
Google Scholar
Tomova, A. et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol. Behav. 138, 179–187 (2015).
Google Scholar
Comprehensive Physiology. 1 edn, (Wiley, 2011).
Maier, T. V. et al. Impact of dietary resistant starch on the human gut microbiome, metaproteome, and metabolome. mBio. 8, e01343–17 (2017).
Wall, R. et al. in Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease Vol. 817 (eds Mark Lyte & John F. Cryan) 221–239 (Springer New York, 2014).
Jaglin, M. et al. Indole, a signaling molecule produced by the gut microbiota, negatively impacts emotional behaviors in rats. Front. Neurosci. 12, 216 (2018).
Google Scholar
Perez-Burgos, A. et al. Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. Am. J. Physiol.-Gastrointest. Liver Physiol. 304, G211–G220 (2013).
Google Scholar
Sgritta, M. et al. Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron 101, 246–259.e246 (2019).
Google Scholar
De Vadder, F. et al. Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks. Proc. Natl Acad. Sci. 115, 6458–6463 (2018).
Google Scholar
Mayer, E. A. The neurobiology of stress and gastrointestinal disease. Gut 47, 861–869 (2000).
Google Scholar
Sudo, N. et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice: commensal microbiota and stress response. J. Physiol. 558, 263–275 (2004).
Google Scholar
Dinan, T. G. et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130, 304–311 (2006).
Google Scholar
Wang, B. et al. The human microbiota in health and disease. Engineering 3, 71–82 (2017).
Google Scholar
Hoban, A. E. et al. Microbial regulation of microRNA expression in the amygdala and prefrontal cortex. Microbiome 5, 102 (2017).
Google Scholar
Chen, J.-j et al. Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice. Behav. Brain Res. 322, 34–41 (2017).
Google Scholar
Hildebrandt, M. A. et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716–1724.e1712 (2009).
Google Scholar
Biagi, E. et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 5, e10667 (2010).
Google Scholar
Devkota, S. et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature 487, 104–108 (2012).
Google Scholar
Karstens, A. J. et al. Associations of the Mediterranean diet with cognitive and neuroimaging phenotypes of dementia in healthy older adults. Am. J. Clin. Nutr. 109, 361–368 (2019).
Google Scholar
Sánchez-Villegas, A., Henríquez, P., Bes-Rastrollo, M. & Doreste, J. Mediterranean diet and depression. Public Health Nutr. 9, 1104–1109 (2006).
Google Scholar
Cavaleri, F. & Bashar, E. Potential synergies of β -hydroxybutyrate and butyrate on the modulation of metabolism, inflammation, cognition, and general health. J. Nutr. Metab. 2018, 1–13 (2018).
Google Scholar
Olson, C. A. et al. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell 173, 1728–1741.e1713 (2018).
Google Scholar
Clarke, G. et al. Gut reactions: breaking down xenobiotic–microbiome interactions. Pharmacol. Rev. 71, 198–224 (2019).
Google Scholar
Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).
Google Scholar
Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
Google Scholar
Jin, M. et al. Antidepressant fluoxetine induces multiple antibiotics resistance in Escherichia coli via ROS-mediated mutagenesis. Environ. Int. 120, 421–430 (2018).
Google Scholar
Alexander, K. L., Targan, S. R. & Elson, C. O. 3rd Microbiota activation and regulation of innate and adaptive immunity. Immunol. Rev. 260, 206–220 (2014).
Google Scholar
Hapfelmeier, S. et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 328, 1705–1709 (2010).
Google Scholar
Zhao, Q. & Elson, C. O. Adaptive immune education by gut microbiota antigens. Immunology 154, 28–37 (2018).
Google Scholar
Owaga, E. et al. Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases. Int. J. Mol. Sci. 16, 20841–20858 (2015).
Google Scholar
Sekirov, I., Russell, S. L., Antunes, L. C. M. & Finlay, B. B. Gut microbiota in health and disease. Physiol. Rev. 90, 859–904 (2010).
Google Scholar
Salzman, N. H. et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11, 76–82 (2010).
Google Scholar
Maynard, C. L., Elson, C. O., Hatton, R. D. & Weaver, C. T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231–241 (2012).
Google Scholar
Bager, P., Wohlfahrt, J. & Westergaard, T. Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clin. Exp. Allergy. J. Br. Soc. Allergy. Clin. Immunol. 38, 634–642 (2008).
Google Scholar
Durko, T., Gryczyński, M. & Dabrowski, R. Evaluation of collagenous protein levels in inflamed middle ear mucosa. Otolaryngologia Pol. = Pol. Otolaryngol. 45, 208–212 (1991).
Google Scholar
Thomson, A. W. & Knolle, P. A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10, 753–766 (2010).
Google Scholar
Cullender, TylerC. et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe 14, 571–581 (2013).
Google Scholar
Macpherson, A. J. & Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662–1665 (2004).
Google Scholar
Helgeland, L. et al. Microbial colonization induces oligoclonal expansions of intraepithelial CD8 T cells in the gut. Eur. J. Immunol. 34, 3389–3400 (2004).
Google Scholar
Lamont, R. J., Koo, H. & Hajishengallis, G. The oral microbiota: dynamic communities and host interactions. Nat. Rev. Microbiol. 16, 745–759 (2018).
Google Scholar
Marsh, P. D. Are dental diseases examples of ecological catastrophes? Microbiology 149, 279–294 (2003).
Google Scholar
Duran-Pinedo, A. E. et al. Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. ISME J. 8, 1659–1672 (2014).
Google Scholar
Maekawa, T. et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe 15, 768–778 (2014).
Google Scholar
Hilty, M. et al. Disordered microbial communities in asthmatic airways. PLoS One 5, e8578 (2010).
Google Scholar
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J. & Huffnagle, G. B. The microbiome and the respiratory tract. Annu. Rev. Physiol. 78, 481–504 (2016).
Google Scholar
Barcik, W., Boutin, R. C. T., Sokolowska, M. & Finlay, B. B. The role of lung and gut microbiota in the pathology of asthma. Immunity 52, 241–255 (2020).
Google Scholar
Soroosh, P. et al. Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J. Exp. Med. 210, 775–788 (2013).
Google Scholar
Sellge, G. & Kufer, T. A. PRR-signaling pathways: learning from microbial tactics. Semin. Immunol. 27, 75–84 (2015).
Google Scholar
Gollwitzer, E. S. et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat. Med. 20, 642–647 (2014).
Google Scholar
Lai, Y. et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 15, 1377–1382 (2009).
Google Scholar
Lai, Y. et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J. Investig. Dermatol. 130, 2211–2221 (2010).
Google Scholar
Naik, S. et al. Compartmentalized control of skin immunity by resident commensals. Science 337, 1115–1119 (2012).
Google Scholar
Aiyar, A. et al. Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections. Front. Cell. Infect. Microbiol. 4, 72 (2014).
Google Scholar
Brotman, R. M. et al. Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections. Vaccine 32, 1543–1552 (2014).
Google Scholar
Gilbert, N. M. et al. Gardnerella vaginalis and prevotella bivia trigger distinct and overlapping phenotypes in a mouse model of bacterial vaginosis. J. Infect. Dis. 220, 1099–1108 (2019).
Google Scholar
Garcia, E. M., Kraskauskiene, V., Koblinski, J. E. & Jefferson, K. K. Interaction of Gardnerella vaginalis and vaginolysin with the apical versus basolateral face of a three-dimensional model of vaginal epithelium. Infect. Immun. 87, e00646–00618 (2019).
Google Scholar
Doerflinger, S. Y., Throop, A. L. & Herbst-Kralovetz, M. M. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J. Infect. Dis. 209, 1989–1999 (2014).
Google Scholar
Fichorova, R. N. et al. The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sexually Transmitted Infect. 89, 460–466 (2013).
Google Scholar
Lau, K. et al. Bridging the gap between gut microbial dysbiosis and cardiovascular diseases. Nutrients. 9, 859 (2017).
Sanchez-Rodriguez, E. et al. The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases. Nutrients. 12, 605 (2020).
DeStefano, F. et al. Dental disease and risk of coronary heart disease and mortality. BMJ 306, 688–691 (1993).
Google Scholar
Schenkein, H. A., Papapanou, P. N., Genco, R. & Sanz, M. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontology 2000. 83, 90–106 (2020).
Google Scholar
D’Aiuto, F. et al. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am. Heart J. 151, 977–984 (2006).
Google Scholar
Ramírez, J. H. et al. Biomarkers of cardiovascular disease are increased in untreated chronic periodontitis: a case control study. Aust. Dent. J. 59, 29–36 (2014).
Google Scholar
Roncal, C. et al. Trimethylamine-N-oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease. Sci. Rep. 9, 15580 (2019).
Google Scholar
Zeisel, S. H. & Warrier, M. Trimethylamine N-oxide, the microbiome, and heart and kidney disease. Annu. Rev. Nutr. 37, 157–181 (2017).
Google Scholar
Liu, T., Zhang, L., Joo, D. & Sun, S.-C. NF-κB signaling in inflammation. Signal Transduct. Target. Ther. 2, 17023 (2017).
Google Scholar
Yoshida, N. et al. A possible beneficial effect of bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases. Sci. Rep. 10, 13009 (2020).
Google Scholar
Mathewson, N. D. et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat. Immunol. 17, 505–513 (2016).
Google Scholar
Bartolomaeus, H. et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation 139, 1407–1421, (2019).
Kvakan, H. et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119, 2904–2912 (2009).
Google Scholar
Wang, L. et al. Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro)renin receptor and intrarenal renin-angiotensin system. J. Hypertens. 35, 1899–1908 (2017).
Google Scholar
Wu, Y., Xu, H., Tu, X. & Gao, Z. The role of short-chain fatty acids of gut microbiota origin in hypertension. 12, 730809 (2021).
Li, Q. et al. Gut microbiota: a novel regulator of cardiovascular disease and key factor in the therapeutic effects of flavonoids. Front. Pharmacol. 12, 651926 (2021).
Google Scholar
Ferlay J. et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer. (2020).
Golemis, E. A. et al. Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev. 32, 868–902 (2018).
Google Scholar
Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 61, 1–241, (1994).
Farrell, J. J. et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 61, 582–588 (2012).
Google Scholar
Michaud, D. S. et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 62, 1764–1770 (2013).
Google Scholar
Fan, X. et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 67, 120–127 (2018).
Google Scholar
Peters, B. A. et al. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 77, 6777–6787 (2017).
Google Scholar
Sami, A. et al. The role of the microbiome in oral squamous cell carcinoma with insight into the microbiome-treatment axis. Int. J. Mol. Sci. 21, 8061 (2020).
Cao, W. et al. Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells. Sci. Rep. 5, 8477 (2015).
Google Scholar
Kuboniwa, M. et al. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect. 10, 122–128 (2008).
Google Scholar
Donehower, L. A. Phosphatases reverse p53-mediated cell cycle checkpoints. Proc. Natl. Acad. Sci. USA. 111, 7172–7173, (2014).
Zhou, Y. et al. Noncanonical activation of β-catenin by Porphyromonas gingivalis. Infect. Immun. 83, 3195–3203 (2015).
Google Scholar
Takayama, S. et al. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases. Oncol. Rep. 21, 205–210 (2009).
Google Scholar
Vyhnalova, T., Danek, Z., Gachova, D. & Linhartova, P. B. The role of the oral microbiota in the etiopathogenesis of oral squamous cell carcinoma. Microorganisms. 9, 1549 (2021).
Atarashi, K. et al. Ectopic colonization of oral bacteria in the intestine drives T(H)1 cell induction and inflammation. Science 358, 359–365 (2017).
Google Scholar
Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207–215 (2013).
Google Scholar
Gomes, S. et al. Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma. Sci. Rep. 9, 12838 (2019).
Google Scholar
Peters, B. A. et al. The microbiome in lung cancer tissue and recurrence-free survival. Cancer Epidemiol. Biomark. Prev. 28, 731–740 (2019).
Google Scholar
Jin, C. et al. Commensal microbiota promote lung cancer development via γδ T cells. Cell 176, 998–1013.e1016 (2019).
Google Scholar
Tsay, J.-C. J. et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am. J. Respir. Crit. Care Med. 198, 1188-1198, (2018).
Tsay, J. J. et al. Lower airway dysbiosis affects lung cancer progression. Cancer Discov. 11, 293–307 (2021).
Google Scholar
Honda, K. & Littman, D. R. The microbiota in adaptive immune homeostasis and disease. Nature 535, 75–84 (2016).
Google Scholar
Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254–258 (2012).
Google Scholar
Li, S. et al. Tumorigenic bacteria in colorectal cancer: mechanisms and treatments. Cancer Biol. Med. 19, 147–162 (2021).
Chen, J., Pitmon, E. & Wang, K. Microbiome, inflammation and colorectal cancer. Semin Immunol. 32, 43–53 (2017).
Google Scholar
Dai, Z. et al. The role of microbiota in the development of colorectal cancer. Int. J. Cancer 145, 2032–2041 (2019).
Google Scholar
Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
Google Scholar
de Groot, P. F. et al. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. PLOS One. 12, e0188475 (2017).
Google Scholar
Mariño, E. et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat. Immunol. 18, 552–562 (2017).
Google Scholar
Leiva-Gea, I. et al. Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control study. Diabetes Care. 41, 2385–2395 (2018).
Google Scholar
Zhou, H. et al. Gut microbiota profile in patients with type 1 diabetes based on 16S rRNA gene sequencing: a systematic review. Dis. Mark. 2020, 3936247 (2020).
Vatanen, T. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562, 589–594 (2018).
Google Scholar
Suzuki, T. et al. Diabetogenic effects of lymphocyte transfusion on the NOD or NOD nude mouse. Karger (1985).
Acosta-Montaño, P. et al. Fatty acid and lipopolysaccharide effect on beta cells proteostasis and its impact on insulin secretion. Cells 8, 884 (2019).
Google Scholar
Devaraj, S., Dasu, M. R., Park, S. H. & Jialal, I. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 52, 1665–1668 (2009).
Google Scholar
Gülden, E. et al. Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice. PLoS One 8, e75385 (2013).
Google Scholar
Li, J., Wang, X., Zhang, F. & Yin, H. Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharm. Ther. 138, 441–451 (2013).
Google Scholar
Hou, K. et al. Reconstruction of intestinal microecology of Type 2 diabetes by fecal microbiota transplantation: why and how. Bosn. J. Basic Med. Sci. (2021).
Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLOS One. 5, e9085 (2010).
Google Scholar
Almugadam, B. S. et al. Alterations of gut microbiota in type 2 diabetes individuals and the confounding effect of antidiabetic agents. J. Diabetes Res. 2020, 7253978 (2020).
Google Scholar
Gomes, J. M. G., Costa, J. A. & Alfenas, R. C. G. Metabolic endotoxemia and diabetes mellitus: a systematic review. Metabolism 68, 133–144 (2017).
Google Scholar
Shapiro, H., Kolodziejczyk, A. A., Halstuch, D. & Elinav, E. Bile acids in glucose metabolism in health and disease. J. Exp. Med. 215, 383–396 (2018).
Google Scholar
Psichas, A. et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int. J. Obes. 39, 424–429 (2015).
Google Scholar
Takahashi, D. et al. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells. EBioMedicine 58, 102913 (2020).
Google Scholar
He, J. et al. The oral microbiome diversity and its relation to human diseases. Folia Microbiol. 60, 69–80 (2015).
Google Scholar
Xiao, E. et al. Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity. Cell Host Microbe 22, 120–128.e124 (2017).
Google Scholar
Radzicka, S., Pietryga, M., Iciek, R. & Brązert, J. The role of visfatin in pathogenesis of gestational diabetes (GDM). Ginekol. Pol. 89, 518–521 (2018).
Google Scholar
Gomez-Arango, L. F. et al. Connections between the gut microbiome and metabolic hormones in early pregnancy in overweight and obese women. Diabetes 65, 2214–2223 (2016).
Google Scholar
Koren, O. et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150, 470–480 (2012).
Google Scholar
Cortez, R. V. et al. Microbiome and its relation to gestational diabetes. Endocrine 64, 254–264 (2019).
Google Scholar
Crusell, M. K. W. et al. Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome 6, 89 (2018).
Google Scholar
Ponzo, V. et al. The microbiota composition of the offspring of patients with gestational diabetes mellitus (GDM). PLoS One 14, e0226545 (2019).
Google Scholar
Wang, J. et al. Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus. Gut 67, 1614–1625 (2018).
Google Scholar
van Woerden, H. C. et al. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect. Dis. 13, 69 (2013).
Google Scholar
Millares, L. et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur. J. Clin. Microbiol Infect. Dis. 33, 1101–1111 (2014).
Google Scholar
Han, M. K. et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet Respir. Med. 2, 548–556 (2014).
Google Scholar
Huang, Y. J. et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J. Allergy Clin. Immunol. 127, 372–381 (2011). e371–373.
Google Scholar
Essilfie, A. T. et al. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67, 588–599 (2012).
Google Scholar
Alnahas, S. et al. IL-17 and TNF-α are key mediators of moraxella catarrhalis triggered exacerbation of allergic airway inflammation. Front. Immunol. 8, 1562 (2017).
Google Scholar
Garcia-Nuñez, M. et al. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. J. Clin. Microbiol. 52, 4217–4223 (2014).
Google Scholar
Sokolowska, M. et al. Microbiome and asthma. Asthma Res. Pract. 4, 1 (2018).
Google Scholar
Roussos, A. et al. Increased prevalence of irritable bowel syndrome in patients with bronchial asthma. Respir. Med. 97, 75–79 (2003).
Google Scholar
Rutten, E. P. A., Lenaerts, K., Buurman, W. A. & Wouters, E. F. M. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest 145, 245–252 (2014).
Google Scholar
Sprooten, R. T. M. et al. Increased small intestinal permeability during severe acute exacerbations of COPD. Respiration 95, 334–342 (2018).
Google Scholar
Ottiger, M. et al. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease. Nutrition 45, 135–141.e131 (2018).
Google Scholar
Arrieta, M. C. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 7, 307ra152 (2015).
Google Scholar
Roduit, C. et al. High levels of butyrate and propionate in early life are associated with protection against atopy. Allergy 74, 799–809 (2019).
Google Scholar
Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).
Google Scholar
Cait, A. et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids. Mucosal. Immunol. 11, 785–795 (2018).
Google Scholar
Tulic, M. K., Piche, T. & Verhasselt, V. Lung-gut cross-talk: evidence, mechanisms and implications for the mucosal inflammatory diseases. Clin. Exp. Allergy 46, 519–528 (2016).
Google Scholar
Huang, Y. et al. S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science 359, 114–119 (2018).
Google Scholar
Perrone, E. E. et al. Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis. Shock 38, 68–75 (2012).
Google Scholar
Coopersmith, C. M. et al. Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit. Care Med. 31, 1630–1637 (2003).
Google Scholar
Gleeson, K., Eggli, D. F. & Maxwell, S. L. Quantitative aspiration during sleep in normal subjects. Chest 111, 1266–1272 (1997).
Google Scholar
Bassis, C. M. et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio 6, e00037 (2015).
Google Scholar
Segal, L. N. et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1, 19 (2013).
Google Scholar
Durack, J. et al. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment. J. Allergy Clin. Immunol. 140, 63–75 (2017).
Google Scholar
Aaron, S. D. et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 349–355 (2001).
Google Scholar
Thomas, P. S. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol. Cell Biol. 79, 132–140 (2001).
Google Scholar
Jousilahti, P. et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann. Allergy Asthma Immunol. 89, 381–385 (2002).
Google Scholar
de Steenhuijsen Piters, W. A. et al. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J. 10, 97–108 (2016).
Google Scholar
Vissing, N. H., Chawes, B. L. & Bisgaard, H. Increased risk of pneumonia and bronchiolitis after bacterial colonization of the airways as neonates. Am. J. Respir. Crit. Care Med. 188, 1246–1252 (2013).
Google Scholar
Selwyn, P. A. et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 2, 267–272 (1988).
Google Scholar
Segal, L. N. et al. Anaerobic bacterial fermentation products increase tuberculosis risk in antiretroviral-drug-treated HIV patients. Cell Host Microbe 21, 530–537.e534 (2017).
Google Scholar
Gomez, J. C. et al. Mechanisms of interferon-γ production by neutrophils and its function during Streptococcus pneumoniae pneumonia. Am. J. Respir. Cell Mol. Biol. 52, 349–364 (2015).
Google Scholar
Tsai, H. C., Velichko, S., Hung, L. Y. & Wu, R. IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. Clin. Dev. Immunol. 2013, 267971 (2013).
Google Scholar
Salk, H. M. et al. Taxa of the nasal microbiome are associated with influenza-specific IgA response to live attenuated influenza vaccine. PLoS One 11, e0162803 (2016).
Google Scholar
Fan, J. et al. The lung tissue microbiota features of 20 deceased patients with COVID-19. J. Infect. 81, e64–e67 (2020).
Google Scholar
Han Y, Jia Z, Shi J, Wang W, He K. The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis. Bioimpacts 12,139–146 (2022).
Sulaiman, I. et al. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Nat. Microbiol. 6, 1245–1258 (2021).
Google Scholar
Schuijt, T. J. et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 65, 575 (2016).
Google Scholar
Yeoh, Y. K. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698 (2021).
Google Scholar
Kochar, B., Orkaby, A. R., Ananthakrishnan, A. N. & Ritchie, C. S. Frailty in inflammatory bowel diseases: an emerging concept. Ther. Adv. Gastroenterol. 14, 17562848211025474 (2021).
Google Scholar
Lucas López, R., Grande Burgos, M. J., Gálvez, A. & Pérez Pulido, R. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. APMIS 125, 3–10 (2017).
Google Scholar
Leone, V., Chang, E. B. & Devkota, S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J. Gastroenterol. 48, 315–321 (2013).
Google Scholar
McGuckin, M. A. et al. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis. 15, 100–113 (2009).
Google Scholar
Kaistha, A. & Levine, J. Inflammatory bowel disease: the classic gastrointestinal autoimmune disease. Curr. Probl. Pediatr. Adolesc. Health Care. 44, 328–334 (2014).
Google Scholar
Marcuzzi, A. et al. Genetic and functional profiling of Crohn’s disease: autophagy mechanism and susceptibility to infectious diseases. Biomed. Res. Int. 2013, 297501 (2013).
Google Scholar
Kleessen, B., Kroesen, A. J., Buhr, H. J. & Blaut, M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37, 1034–1041 (2002).
Google Scholar
Ahmed, I. et al. Microbiome, metabolome and inflammatory bowel disease. Microorganisms. 4, 20 (2016).
Manichanh, C., Borruel, N., Casellas, F. & Guarner, F. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599–608 (2012).
Google Scholar
Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).
Google Scholar
Wang, Z. K. et al. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J. Gastroenterol. 20, 14805–14820 (2014).
Google Scholar
Yu, Q. et al. Enterohepatic helicobacter species as a potential causative factor in inflammatory bowel disease: a meta-analysis. Medicines94, e1773 (2015).
Google Scholar
Ni, J., Wu, G. D., Albenberg, L. & Tomov, V. T. Gut microbiota and IBD: causation or correlation? Nat. Rev. Gastroenterol. Hepatol. 14, 573–584 (2017).
Google Scholar
Kitamoto, S. et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell 182, 447–462.e414 (2020).
Google Scholar
Derrien, M. et al. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1, 254–268 (2010).
Google Scholar
She, Y. Y. et al. Periodontitis and inflammatory bowel disease: a meta-analysis. BMC Oral. Health 20, 67 (2020).
Google Scholar
Said, H. S. et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res. 21, 15–25 (2014).
Google Scholar
Vavricka, S. R. et al. Periodontitis and gingivitis in inflammatory bowel disease: a case-control study. Inflamm. Bowel Dis. 19, 2768–2777 (2013).
Google Scholar
Walker, E. R., McGee, R. E. & Druss, B. G. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72, 334–341 (2015).
Google Scholar
Varghese, F. P. & Brown, E. S. The hypothalamic-pituitary-adrenal axis in major depressive disorder: a brief primer for primary care physicians. Prim. Care Companion J. Clin. Psychiatry 3, 151 (2001).
Google Scholar
Hao, W. Z., Li, X. J., Zhang, P. W. & Chen, J. X. A review of antibiotics, depression, and the gut microbiome. Psychiatry Res. 284, 112691 (2020).
Google Scholar
Sherwin, E., Dinan, T. G. & Cryan, J. F. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann. N.Y. Acad. Sci. 1420, 5–25 (2018).
Google Scholar
Desbonnet, L. et al. Microbiota is essential for social development in the mouse. Mol. Psychiatry 19, 146–148 (2014).
Google Scholar
de Punder, K. & Pruimboom, L. Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Front. Immunol. 6, 223 (2015).
Peirce, J. M. & Alviña, K. The role of inflammation and the gut microbiome in depression and anxiety. J. Neurosci. Res. 97, 1223–1241 (2019).
Google Scholar
Jiang, H. et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behav. Immun. 48, 186–194 (2015).
Google Scholar
Winter, G., Hart, R. A., Charlesworth, R. P. & Sharpley, C. F. Gut microbiome and depression: what we know and what we need to know. Rev. Neurosci. 29, 629–643 (2018).
Google Scholar
Luo, Y. et al. Gut microbiota regulates mouse behaviors through glucocorticoid receptor pathway genes in the hippocampus. Transl. Psychiatry 8, 1–10 (2018).
Google Scholar
Heijtz, R. D. et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl Acad. Sci. 108, 3047–3052 (2011).
Google Scholar
Crumeyrolle-Arias, M. et al. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology 42, 207–217 (2014).
Google Scholar
Hsiao, ElaineY. et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451–1463 (2013).
Google Scholar
Finegold, S. M. et al. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35, S6–S16 (2002).
Google Scholar
Adams, J. B. et al. Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 11, 22 (2011).
Google Scholar
Kang, D.-W. et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5, 10 (2017).
Google Scholar
Sherwin, E., Rea, K., Dinan, T. G. & Cryan, J. F. A gut (microbiome) feeling about the brain. Curr. Opin. Gastroenterol. 32, 96–102 (2016).
Google Scholar
Minter, M. R. et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci. Rep. 6, 30028 (2016).
Google Scholar
Juárez, I., Gratton, A. & Flores, G. Ontogeny of altered dendritic morphology in the rat prefrontal cortex, hippocampus, and nucleus accumbens following Cesarean delivery and birth anoxia. J. Comp. Neurol. 507, 1734–1747 (2008).
Google Scholar
Li, W. et al. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Sci. China Life Sci. 60, 1223–1233 (2017).
Google Scholar
Li, C. et al. Gut microbiota differs between parkinson’s disease patients and healthy controls in northeast China. Front. Mol. Neurosci. 12, 171 (2019).
Google Scholar
Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339–1353.e1321 (2016).
Google Scholar
Scheperjans, F. et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov. Disord. 30, 350–358 (2015).
Google Scholar
Vogt, N. M. et al. Gut microbiome alterations in Alzheimer’s disease. Sci. Rep. 7, 13537 (2017).
Google Scholar
Cattaneo, A. et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging 49, 60–68 (2017).
Google Scholar
Hill, J. M. et al. Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD). Front. Aging Neurosci. 6, 127 (2014).
Google Scholar
Singh, V. et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J. Neurosci. 36, 7428–7440 (2016).
Google Scholar
Houlden, A. et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav. Immun. 57, 10–20 (2016).
Google Scholar
Caso, J. R. et al. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R979–R985 (2009).
Google Scholar
Lin, D. et al. Association between the oral microbiome and brain resting state connectivity in smokers. Neuroimage 200, 121–131 (2019).
Google Scholar
Hicks, S. D. et al. Oral microbiome activity in children with autism spectrum disorder. Autism Res. 11, 1286–1299 (2018).
Google Scholar
Wingfield, B. et al. Variations in the oral microbiome are associated with depression in young adults. Sci. Rep. 11, 15009 (2021).
Google Scholar
Yussof, A. et al. A meta-analysis of the effect of binge drinking on the oral microbiome and its relation to Alzheimer’s disease. Sci. Rep. 10, 19872 (2020).
Google Scholar
Mihaila, D. et al. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function. PLoS One 14, e0218252 (2019).
Google Scholar
Yang, I. et al. The oral microbiome and inflammation in mild cognitive impairment. Exp. Gerontol. 147, 111273 (2021).
Google Scholar
Liu, X. X. et al. Analysis of salivary microbiome in patients with Alzheimer’s disease. J. Alzheimers Dis. 72, 633–640 (2019).
Google Scholar
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 395, 709–733, (2020).
Pluznick, J. L. The gut microbiota in kidney disease. Science 369, 1426–1427 (2020).
Google Scholar
Barros, A. F. et al. Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients? Future Microbiol. 10, 517–526 (2015).
Google Scholar
Li, L. et al. Periodontitis exacerbates and promotes the progression of chronic kidney disease through oral flora, cytokines, and oxidative stress. Front. Microbiol. 12, 656372 (2021).
Kshirsagar, A. V. et al. Antibodies to periodontal organisms are associated with decreased kidney function. The dental atherosclerosis risk in communities study. Blood Purif. 25, 125–132 (2007).
Google Scholar
Bastos, J. A. et al. Identification of periodontal pathogens and severity of periodontitis in patients with and without chronic kidney disease. Arch. Oral. Biol. 56, 804–811 (2011).
Google Scholar
Sharma, P. et al. Association between periodontitis and mortality in stages 3–5 chronic kidney disease: NHANES III and linked mortality study. J. Clin. Periodontol. 43, 104–113 (2016).
Google Scholar
Yang, T., Richards, E. M., Pepine, C. J. & Raizada, M. K. The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease. Nat. Rev. Nephrol. 14, 442–456 (2018).
Google Scholar
Kanbay, M. et al. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Int. Urol. Nephrol. 50, 1453–1466 (2018).
Google Scholar
Wang, I.-K. et al. Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients. Appl. Environ. Microbiol. 78, 1107–1112 (2012).
Google Scholar
Mafra, D. & Fouque, D. Gut microbiota and inflammation in chronic kidney disease patients. Clin Kidney J. 8, 332–334 (2015).
Google Scholar
Pan, W. & Kang, Y. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies. Int. Urol. Nephrol. 50, 289–299 (2018).
Google Scholar
Vaziri, N. D. et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83, 308–315 (2013).
Google Scholar
Li, F. et al. Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Front. Cell. Infect. Microbiol. 9, 206 (2019).
Google Scholar
Lun, H. et al. Altered gut microbiota and microbial biomarkers associated with chronic kidney disease. Microbiologyopen 8, e00678 (2019).
Google Scholar
Mafra, D. et al. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol. 9, 399–410 (2014).
Google Scholar
Lobel, L. et al. Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function. Science 369, 1518–1524 (2020).
Google Scholar
Krishnamurthy, V. M. R. et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 81, 300–306 (2012).
Google Scholar
Chung, S., Barnes, J. L. & Astroth, K. S. Gastrointestinal microbiota in patients with chronic kidney disease: a systematic review. Adv. Nutr. 10, 888–901 (2019).
Google Scholar
Andersen, K. et al. Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J. Am. Soc. Nephrol. 28, 76–83 (2017).
Google Scholar
Poesen, R. et al. Metabolism, protein binding, and renal clearance of microbiota–derived p-cresol in patients with CKD. Clin. J. Am. Soc. Nephrol. 11, 1136–1144 (2016).
Google Scholar
Castillo-Rodriguez, E. et al. Impact of altered intestinal microbiota on chronic kidney disease progression. Toxins 10, 300 (2018).
Google Scholar
Mutsaers, H. A. M. et al. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: implications for chronic kidney disease pathophysiology. Toxicol. Vitr. 29, 1868–1877 (2015).
Google Scholar
Watanabe, H. et al. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 83, 582–592 (2013).
Google Scholar
Bolati, D. et al. Indoxyl sulfate induces epithelial-to-mesenchymal transition in rat kidneys and human proximal tubular cells. Am. J. Nephrol. 34, 318–323 (2011).
Google Scholar
Sun, C.-Y., Hsu, H.-H. & Wu, M.-S. p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. Nephrol. Dial. Transplant. 28, 70–78 (2013).
Google Scholar
Tang, W. W. et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 116, 448–455 (2015).
Google Scholar
Kim, R. B. et al. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. Kidney Int. 89, 1144–1152 (2016).
Google Scholar
Osna, N. A., Donohue, T. M. Jr. & Kharbanda, K. K. Alcoholic liver disease: pathogenesis and current management. Alcohol Res. 38, 147–161 (2017).
Google Scholar
Brůha, R. et al. Alcoholic liver disease. Prague Med. Rep. 110, 181–190 (2009).
Google Scholar
Tripathi, A. et al. The gut–liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15, 397–411 (2018).
Google Scholar
Mouzaki, M. et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58, 120–127 (2013).
Google Scholar
Raman, M. et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 11, 868–875 (2013). e861-863.
Google Scholar
Wong, V. W. et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis–a longitudinal study. PLoS One 8, e62885 (2013).
Google Scholar
Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562–572 (2011).
Google Scholar
Payne, C. M. et al. Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 28, 215–222 (2007).
Google Scholar
Morgan, M. J. & Liu, Z. G. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 21, 103–115 (2011).
Google Scholar
Corbin, K. D. & Zeisel, S. H. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr. Opin. Gastroenterol. 28, 159–165 (2012).
Google Scholar
Spencer, M. D. et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140, 976–986 (2011).
Google Scholar
Schwabe, R. F. & Luedde, T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat. Rev. Gastroenterol. Hepatol. 15, 738–752 (2018).
Google Scholar
Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324–1332 (2007).
Google Scholar
Arrese, M., Cabrera, D., Kalergis, A. M. & Feldstein, A. E. Innate Immunity and Inflammation in NAFLD/NASH. Dig. Dis. Sci. 61, 1294–1303 (2016).
Google Scholar
Han, P., Sun, D. & Yang, J. Interaction between periodontitis and liver diseases. Biomed. Rep. 5, 267–276 (2016).
Google Scholar
Yoneda, M. et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 12, 16 (2012).
Google Scholar
Akinkugbe, A. A. et al. Periodontitis and non-alcoholic fatty liver disease, a population-based cohort investigation in the study of health in Pomerania. J. Clin. Periodontol. 44, 1077–1087 (2017).
Google Scholar
Hajishengallis, G. et al. Complement involvement in periodontitis: molecular mechanisms and rational therapeutic approaches. Adv. Exp. Med. Biol. 865, 57–74 (2015).
Google Scholar
Acharya, C., Sahingur, S. E. & Bajaj, J. S. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight. 2, e94416 (2017).
Seki, E. & Schnabl, B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J. Physiol. 590, 447–458 (2012).
Google Scholar
Silva Santos, P. S., Fernandes, K. S. & Gallottini, M. H. Assessment and management of oral health in liver transplant candidates. J. Appl Oral. Sci. 20, 241–245 (2012).
Google Scholar
Ling, Z. et al. Decreased diversity of the oral microbiota of patients with hepatitis b virus-induced chronic liver disease: a pilot project. Sci. Rep. 5, 17098 (2015).
Google Scholar
Quigley, E. M. M. & Gajula, P. Recent advances in modulating the microbiome. F1000Research. 9, 46 (2020).
Google Scholar
Cunningham, M. et al. Applying probiotics and prebiotics in new delivery formats—is the clinical evidence transferable? Trends Food Sci. Technol. 112, 495–506 (2021).
Google Scholar
Miller, L. E., Zimmermann, A. K. & Ouwehand, A. C. Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit. World J. Gastroenterol. 22, 5122 (2016).
Google Scholar
Anderson, A. D. G. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53, 241–245 (2004).
Google Scholar
Doron, S. & Snydman, D. R. Risk and safety of probiotics. Clin. Infect. Dis. 60, S129–S134 (2015).
Google Scholar
Adamberg, S. et al. Survival and synergistic growth of mixed cultures of bifidobacteria and lactobacilli combined with prebiotic oligosaccharides in a gastrointestinal tract simulator. Microb. Ecol. Health Dis. 25, 3402 (2014).
Forchielli, M. L. & Walker, W. A. The role of gut-associated lymphoid tissues and mucosal defence. Br. J. Nutr. 93, S41–S48 (2005).
Google Scholar
Shoaf, K., Mulvey, G. L., Armstrong, G. D. & Hutkins, R. W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect. Immun. 74, 6920–6928 (2006).
Google Scholar
Belcheva, A. et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158, 288–299 (2014).
Google Scholar
Donohoe, D. R. et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell. 48, 612–626 (2012).
Google Scholar
Sasaki, M. et al. Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. BMC Gastroenterol. 13, 81 (2013).
Google Scholar
Bonfili, L. et al. Microbiota modulation as preventative and therapeutic approach in Alzheimer’s disease. FEBS J. 288, 2836–2855 (2021).
Google Scholar
Kahouli, I. et al. Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model. Appl. Microbiol. Biotechnol. 101, 1999–2019 (2017).
Google Scholar
Hu, J. et al. Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice. J. Biosci. 40, 269–279 (2015).
Google Scholar
Gallo, A. et al. Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate. World J. Gastroenterol. 22, 7186 (2016).
Google Scholar
Lam, V. et al. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 26, 1727–1735 (2012).
Google Scholar
Gan, X. T. et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ. Heart Fail. 7, 491–499 (2014).
Google Scholar
Zhou, A. et al. Gut microbiota: the emerging link to lung homeostasis and disease. J. Bacteriol. 203, e00454–20 (2021).
Chen, J. & Vitetta, L. Modulation of gut microbiota for the prevention and treatment of COVID-19. J. Clin. Med. 10, 2903 (2021).
Google Scholar
Bafeta, A., Koh, M., Riveros, C. & Ravaud, P. Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review. Ann. Intern. Med. 169, 240 (2018).
Google Scholar
Carvalho, B. M. et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55, 2823–2834 (2012).
Google Scholar
Uribe-Herranz, M. et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J. Clin. Investig. 130, 466–479 (2019).
Google Scholar
Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443–1448 (2017).
Google Scholar
Sethi, V. et al. Gut microbiota promotes tumor growth in mice by modulating immune response. Gastroenterology 155, 33–37.e36 (2018).
Google Scholar
Choi, I. J. et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N. Engl. J. Med. 378, 1085–1095 (2018).
Google Scholar
Vetizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079–1084 (2015).
Google Scholar
Hernández, E. et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes 4, 306–315 (2013).
Google Scholar
Kilkkinen, A. et al. Antibiotic use predicts an increased risk of cancer. Int. J. Cancer 123, 2152–2155 (2008).
Google Scholar
Dik, V. K., van Oijen, M. G. H., Smeets, H. M. & Siersema, P. D. Frequent use of antibiotics is associated with colorectal cancer risk: results of a nested case–control study. Dig. Dis. Sci. 61, 255–264 (2016).
Google Scholar
Kyriacou, D. N. & Lewis, R. J. Confounding by indication in clinical research. JAMA 316, 1818 (2016).
Google Scholar
Stripling, J. & Rodriguez, M. Current evidence in delivery and therapeutic uses of fecal microbiota transplantation in human diseases-clostridium difficile disease and beyond. Am. J. Med Sci. 356, 424–432 (2018).
Google Scholar
Kassam, Z., Lee, C. H., Yuan, Y. & Hunt, R. H. Fecal microbiota transplantation for clostridium difficile infection: systematic review and meta-analysis. Am. J. Gastroenterol. 108, 500–508 (2013).
Google Scholar
Ianiro, G. et al. Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: a systematic review and meta-analysis. Urol. Eur. Gastroenterol. J. 6, 1232–1244 (2018).
Google Scholar
Khan, M. Y., Dirweesh, A., Khurshid, T. & Siddiqui, W. J. Comparing fecal microbiota transplantation to standard-of-care treatment for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Eur. J. Gastroenterol. Hepatol. 30, 1309–1317 (2018).
Google Scholar
van Nood, E. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407–415 (2013).
Google Scholar
Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97 (2018).
Google Scholar
Zhang et al. Impact of fecal microbiota transplantation on obesity and metabolic syndrome—a systematic review. Nutrients 11, 2291 (2019).
Google Scholar
Makkawi, S., Camara-Lemarroy, C. & Metz, L. Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS. Neurol. – Neuroimmunol. Neuroinflammation. 5, e459 (2018).
Google Scholar
Peng, J., Xiao, X., Hu, M. & Zhang, X. Interaction between gut microbiome and cardiovascular disease. Life Sci. 214, 153–157 (2018).
Google Scholar
Qi, X. et al. Treating steroid refractory intestinal acute graft-vs.-host disease with fecal microbiota transplantation: a pilot study. Front. Immunol. 9, 2195 (2018).
Google Scholar
Minato, T. et al. Progression of Parkinson’s disease is associated with gut dysbiosis: two-year follow-up study. PLOS One. 12, e0187307 (2017).
Google Scholar
Zhou, D. et al. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci. Rep. 7, 1529 (2017).
Google Scholar
Wortelboer, K., Nieuwdorp, M. & Herrema, H. Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine 44, 716–729 (2019).
Google Scholar
Ademe, M. Benefits of fecal microbiota transplantation: a comprehensive review. J. Infect. Dev. Ctries. 14, 1074–1080 (2020).
Google Scholar
Dailey, F. E., Turse, E. P., Daglilar, E. & Tahan, V. The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications. Curr. Opin. Pharmacol. 49, 29–33 (2019).
Google Scholar
Benech, N. & Sokol, H. Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine. Genome Med. 12, 58 (2020).
Google Scholar
Rosberg-Cody, E. et al. Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice. Microbiology 157, 609–615 (2011).
Google Scholar
Chen, H.-L. et al. Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract. BioMetals 23, 543–554 (2010).
Google Scholar
Koo, O. K., Amalaradjou, M. A. R. & Bhunia, A. K. Recombinant probiotic expressing listeria adhesion protein attenuates listeria monocytogenes virulence in vitro. PLoS One. 7, e29277 (2012).
Google Scholar
Lagenaur, L. A. et al. Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal. Immunol. 4, 648–657 (2011).
Google Scholar
Caluwaerts, S. et al. AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral. Oncol. 46, 564–570 (2010).
Google Scholar
Takiishi, T. et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J. Clin. Investig. 122, 1717–1725 (2012).
Google Scholar
Braat, H. et al. A Phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin. Gastroenterol. Hepatol. 4, 754–759 (2006).
Google Scholar
Suzuki, A., Nakauchi, H. & Taniguchi, H. Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc. Natl Acad. Sci. 100, 5034–5039 (2003).
Google Scholar
Duan, F. F., Liu, J. H. & March, J. C. Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes 64, 1794–1803 (2015).
Google Scholar
Forbes, N. S. Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10, 785–794 (2010).
Google Scholar
Toso, J. F. et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142–152 (2002).
Google Scholar
Brown, J. M. & Wilson, W. R. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4, 437–447 (2004).
Google Scholar
Xiang, S., Fruehauf, J. & Li, C. J. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat. Biotechnol. 24, 697–702 (2006).
Google Scholar
Hwang, I. Y. et al. Reprogramming microbes to be pathogen-seeking killers. ACS Synth. Biol. 3, 228–237 (2014).
Google Scholar
Penninger, J. M., Grant, M. B. & Sung, J. J. Y. The role of angiotensin converting enzyme 2 in modulating gut microbiota, intestinal inflammation, and coronavirus infection. Gastroenterology 160, 39–46 (2021).
Google Scholar
Verma, A. et al. Expression of human ACE2 in lactobacillus and beneficial effects in diabetic retinopathy in mice. Mol. Ther. Methods Clin. Dev. 17, 400 (2020).
Google Scholar
Haga, S. B. in Principles of Gender-Specific Medicine (Third Edition) (ed Marianne J. Legato) 717–732 (Academic Press, 2017).
Sousa, T. et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int. J. Pharm. 363, 1–25 (2008).
Google Scholar
El Aidy, S., van den Bogert, B. & Kleerebezem, M. The small intestine microbiota, nutritional modulation and relevance for health. Curr. Opin. Biotechnol. 32, 14–20 (2015).
Google Scholar
Sun, Y. et al. Effects of intestinal flora on the pharmacokinetics and pharmacodynamics of aspirin in high-altitude hypoxia. PLOS One. 15, e0230197 (2020).
Google Scholar
Matuskova, Z. et al. Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats. PLoS One 9, e87150 (2014).
Google Scholar
Roberts, A. B. et al. Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity. Mol. Pharmacol. 84, 208–217 (2013).
Google Scholar
Saha, J. R., Butler, V. P. Jr., Neu, H. C. & Lindenbaum, J. Digoxin-inactivating bacteria: identification in human gut flora. Science 220, 325–327 (1983).
Google Scholar
Wu, B. et al. In vivo pharmacodynamic and pharmacokinetic effects of metformin mediated by the gut microbiota in rats. Life Sci. 226, 185–192 (2019).
Google Scholar
Crouwel, F., Buiter, H. J. C. & de Boer, N. K. Gut microbiota-driven drug metabolism in inflammatory bowel disease. J. Crohn’s Colitis 15, 307–315 (2020).
Google Scholar
Barnes, K. J., Rowland, A., Polasek, T. M. & Miners, J. O. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins. Eur. J. Clin. Pharmacol. 70, 1097–1106 (2014).
Google Scholar
Klünemann, M. et al. Bioaccumulation of therapeutic drugs by human gut bacteria. Nature 597, 533–538 (2021).
Google Scholar
Al-Asmakh, M. & Zadjali, F. Use of germ-free animal models in microbiota-related research. J. Microbiol. Biotechnol. 25, 1583–1588 (2015).
Google Scholar
Yi, P. & Li, L. The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host. Vet. Microbiol. 157, 1–7 (2012).
Google Scholar
Kennedy, E. A., King, K. Y. & Baldridge, M. T. Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Front Physiol. 9, 1534 (2018).
Peloquin, J. M. & Nguyen, D. D. The microbiota and inflammatory bowel disease: insights from animal models. Anaerobe 24, 102–106 (2013).
Google Scholar
Nguyen, T. L., Vieira-Silva, S., Liston, A. & Raes, J. How informative is the mouse for human gut microbiota research? Dis. Model Mech. 8, 1–16 (2015).
Google Scholar
Schumann, S. et al. Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl. Environ. Microbiol. 78, 1513–1522 (2012).
Google Scholar
link